Spyre Therapeutics expects six trial readouts in 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. MRNA
2. KEYS
3. MRK
4. KLAR
5. TGT
6. LOW
7. PANW
8. UBER
9. SPY
10. BIDU

Go back to Spyre Therapeutics expects six trial readouts in 2026
(NASDAQ: SYRE) Delayed: 108.92 --0 (-0%)
Previous Close $108.92    52 Week High $ 
Open $108.92    52 Week Low $ 
Day High $108.92    P/E N/A 
Day Low $108.92    EPS $ 
Volume 68